Evidence map›Paper›PMID 31528343›Full record

ReviewEvolution, medicine, and public health2019

Differences in mutational processes and intra-tumour heterogeneity between organs: The local selective filter hypothesis.

Mathieu Giraudeau, Tuul Sepp, Beata Ujvari, François Renaud, Aurélie Tasiemski, Benjamin Roche, Jean-Pascal Capp, Frédéric Thomas

Abstract readReview
In one paragraph

Review in Evolution, medicine, and public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mathieu GiraudeauCREEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France.ORCID 0000-0001-8563-1810
Tuul SeppInstitute of Ecology and Earth Sciences, University of Tartu, Vanemuise 46, Tartu 51014, Estonia.ORCID 0000-0002-8677-7069
Beata UjvariSchool of Natural Sciences, University of Tasmania, Private Bag 55, Hobart, Tasmania 7001, Australia.
François RenaudCREEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France.
Aurélie TasiemskiUniversité de Lille-sciences et technologies, UMR 8198 Evo-Eco-Paleo, Villeneuve d'Ascq/CNRS/INSERM/CHU Lille, Institut Pasteur de Lille, U1019-Unité Mixte de Recherche 8204, Lille, France.
Benjamin RocheCREEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France.
Jean-Pascal CappINSA/Université Fédérale de Toulouse, Laboratoire d'Ingénierie des Systèmes Biologiques et des Procédés, UMR CNRS 5504, UMR INRA 792, Toulouse, France.
Frédéric ThomasCREEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extensive diversity (genetic, cytogenetic, epigenetic and phenotypic) exists within and between tumours, but reasons behind these variations, as well as their consistent hierarchical pattern between organs, are poorly understood at the moment. We argue that these phenomena are, at least partially, explainable by the evolutionary ecology of organs' theory, in the same way that environmental adversity shapes mutation rates and level of polymorphism in organisms. Organs in organisms can be considered as specialized ecosystems that are, for ecological and evolutionary reasons, more or less efficient at suppressing tumours. When a malignancy does arise in an organ applying strong selection pressure on tumours, its constituent cells are expected to display a large range of possible surviving strategies, from hyper mutator phenotypes relying on bet-hedging to persist (high mutation rates and high diversity), to few poorly variable variants that become invisible to natural defences. In contrast, when tumour suppression is weaker, selective pressure favouring extreme surviving strategies is relaxed, and tumours are moderately variable as a result. We provide a comprehensive overview of this hypothesis. Lay summary: Different levels of mutations and intra-tumour heterogeneity have been observed between cancer types and organs. Anti-cancer defences are unequal between our organs. We propose that mostly aggressive neoplasms (i.e. higher mutational and ITH levels), succeed in emerging and developing in organs with strong defences.

Indexed as

cancerintra-tumoural heterogeneitymutationselection

Identifiers

PMID31528343
PMCPMC6735757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.